Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
UBS
McKinsey
Queensland Health
US Department of Justice
Express Scripts
McKesson
Boehringer Ingelheim

Generated: August 17, 2018

DrugPatentWatch Database Preview

Leadiant Biosci Inc Company Profile

« Back to Dashboard

What is the competitive landscape for LEADIANT BIOSCI INC, and when can generic versions of LEADIANT BIOSCI INC drugs launch?

LEADIANT BIOSCI INC has eight approved drugs.

There are four US patents protecting LEADIANT BIOSCI INC drugs.

There are fifty patent family members on LEADIANT BIOSCI INC drugs in twenty-four countries and two supplementary protection certificates in one country.

Summary for Leadiant Biosci Inc
International Patents:50
US Patents:4
Tradenames:7
Ingredients:6
NDAs:8

Drugs and US Patents for Leadiant Biosci Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc CARNITOR levocarnitine SOLUTION;ORAL 019257-001 Apr 10, 1986 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes 6,696,493 ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc MATULANE procarbazine hydrochloride CAPSULE;ORAL 016785-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc ADAGEN pegademase bovine INJECTABLE;INJECTION 019818-001 Mar 21, 1990 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Leadiant Biosci Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leadiant Biosci Inc MATULANE procarbazine hydrochloride CAPSULE;ORAL 016785-001 Approved Prior to Jan 1, 1982 3,520,926 ➤ Try a Free Trial
Leadiant Biosci Inc ADAGEN pegademase bovine INJECTABLE;INJECTION 019818-001 Mar 21, 1990 4,179,337 ➤ Try a Free Trial
Leadiant Biosci Inc ABELCET amphotericin b INJECTABLE, LIPID COMPLEX;INJECTION 050724-001 Nov 20, 1995 5,616,334 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Leadiant Biosci Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,914,076 Treating chronic uremic patients undergoing periodical dialysis ➤ Try a Free Trial
5,616,334 Low toxicity drug-lipid systems ➤ Try a Free Trial
4,963,297 Spontaneous vesticulation of multilamellar liposomes ➤ Try a Free Trial
5,948,441 Method for size separation of particles ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Leadiant Biosci Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00649 Netherlands ➤ Try a Free Trial PRODUCT NAME: CYSTEAMINE; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130906
0649 Netherlands ➤ Try a Free Trial PRODUCT NAME: CYSTEAMINE; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130910
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Chubb
Harvard Business School
Cantor Fitzgerald
Citi
Boehringer Ingelheim
Deloitte
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.